Overview of cholesterol and lipoprotein metabolism in the brain, liver and extrahepatic organs

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 7, Issue 3, 1997, Pages 162-168

  Dietschy, J M ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Brain; Cholesterol synthesis; Intestine; LDL cholesterol; Liver

Indexed keywords

EID: 0001493132     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Dietschy JM, Turley SD, Spady DK (1993) Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans. J Lipid Res 34: 1637-1659
2. Turley SD, Spady DK, Dietschy JM (1995) Role of liver in the synthesis of cholesterol and the clearance of low density lipoproteins in the cynomolgus monkey. J Lipid Res 36: 67-79
3. Spady DK, Woollett LA, Dietschy JM (1993) Regulation of plasma LDL-cholesterol levels by dietary cholesterol and fatty acids. Annu Rev Nutr 13: 355-381
4. Schneider WJ, Beisiegel U, Goldstein JL, Brown MS (1982) Purification of the low density lipoprotein receptor, an acidic glycoprotein of 164,000 molecular weight. J Biol Chem 257: 2664-2673
5. Rittenberg D, Schoenheimer R (1937) Deuterium as an indicator in the study of intermediary metabolism. XI. Further studies on the biological uptake of deuterium into organic substances, with special reference to fat and cholesterol formation. J Biol Chem 121: 235-253
6. Herz J, Hamann U, Rogne S, Mykelbost O, Gausepohl H, Stanley KK (1988) Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor. EMBO J 7: 4119-4127
7. Ishibashi S, Herz J, Maeda N, Goldstein JL, Brown MS (1994) The two-receptor model of lipoprotein clearance: tests of the hypothesis in "knockout" mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. Proc Natl Acad Sci USA 91: 4431-4435
8. Tall AR (1993) Plasma cholesteryl ester transfer protein. J Lipid Res 34: 1255-1274
9. Fielding CJ, Fielding PE (1995) Molecular physiology of reverse cholesterol transport. J Lipid Res 36: 211-228
10. Kowal RC, Herz J, Goldstein JL, Esser V, Brown MS (1989) Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins. Proc Natl Acad Sci USA 86: 5810-5814
11. Osono Y, Woollett LA, Herz J, Dietschy JM (1995) Role of the low density lipoprotein receptor in the flux of cholesterol through the plasma and across the tissues of the mouse. J Clin Invest 95: 1124-1132
12. Woollett LA, Osono Y, Herz J, Dietschy JM (1995) Apolipoprotein E competitively inhibits receptor-dependent low density lipoprotein uptake by the liver but has no effect on cholesterol absorption or synthesis in the mouse. Proc Natl Acad Sci USA 92: 12500-12504
13. Spady DK, Meddings JB, Dietschy JM (1986) Kinetic constants for receptor-dependent and receptor-independent low density lipoprotein transport in the tissues of the rat and hamster. J Clin Invest 77: 1474-1481
14. Meddings JB, Dietschy JM (1986) Low density lipoproteins and atherogenesis: implications for modification through alterations in diet and new drug designs. In: Machleidt H (ed) Contributions of Chemistry to Health. Vol. 2. VCH Verlagsfesellschaft mbH, Heidelberg, pp 269-282
15. Newman WP, III, Freedman DS, Voors AW, Gard PD, Srinivasan SR, Cresanta JL, Williamson GD, Webber LS, Berenson GS (1986) Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. The Bogalusa Heart Study. N Engl J Med 314: 138-144
16. Stary HC (1989) Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclerosis 9: 119-132
17. Holme I (1990) An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence. Circulation 82: 1916-1924
18. Kannel WB, Wilson PWF (1992) Efficacy of lipid profiles in prediction of coronary disease. Am Heart J 124: 768-774
19. Pedersen TR, Kjekshus J, Berg K, Haghfelt T, Færgeman O, Thorgeirsson G, Pyörälä K, Miettinen T, Wilhelmsen L, Olsson AG, Wedel H (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344: 1383-1389
20. Epstein FH (1989) The relationship of lifestyle to international trends in CHD. Int J Epidemiol 18: S203-S209
21. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, Macfarlane PW, McKillop JH, Packard CJ (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 333: 1301-1307
22. Jacobs DR, Jr. (1993) Why is low blood cholesterol associated with risk of nonatherosclerotic disease death? Ann Rev Publ Health 14: 95-114
23. Iribarren C, Reed DM, Chen R, Yano K, Dwyer JH (1995) Low serum cholesterol and mortality. Which is the cause and which is the effect? Circulation 92: 2396-2403
24. Connor WE, Johnston R, Lin DS (1969) Metabolism of cholesterol in the tissues and blood of the chick embryo. J Lipid Res 10: 388-394
25. Wilson JD (1970) The measurement of the exchangeable pools of cholesterol in the baboon. J Clin Invest 49: 655-665
26. Lütjohann D, Bruer O, Ahlborg G, Nennesmo I, Sidén Å, Diczfalusy U, Björkhem I (1996) Cholesterol homeostasis in human brain: Evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc Natl Acad Sci USA 93: 9799-9804